Conference Details

23rd Pharmacovigilance 2020 (Virtual Conference)

  • Health and Medicine
  • Conference
  • Dec 16, 2020 - Dec 16, 2021
  • Online
  • Online, India
  • Rating:
Paper Submission Date
11-03-20
Registration Date
11-03-20
Acceptance Notification Date
11-03-20

Description

23rd Pharmacovigilance 2020

“Ensuring safer drugs to market by analyzing latest developments in pharmacovigilance, drug safety and risk management”

16th December 2020, Virtual Conference (Time Zone - IST)

Our conference provides the foundation for strong strategic planning and practical decision-making in your pharmacovigilance programs. This year’s conference will address the current thinking on predicting and assessing risks such as drug-induced liver injury, and the assessment of expectedness of serious adverse reactions during clinical development. Experts will present approaches and engage in dialogs around more extensive and impactful uses of real world data and generation of RWE for safety assessments. A full-day will be devoted to the development, implementation, and assessment of risk management strategies for drugs approved in multiple regions. Please contact KAVITHA on E-mail - kavitha@virtueinsight.co.in or Call - +91 44 24762472

DELEGATE REGISTRATION:

Please note that this is a PAID event and NOT A FREE event (no complimentary passes available). Any invite, email or tickets issued mentioning it as a free pass or free ticket to this event through any third party site will strictly not be accepted by the organizer and entry won’t be granted at the event.

  • Early Bird Discounted Price (Vaild till 15th November 2020) - (INR 7,000 + GST (18%) per delegate)
  • Standard Price  (Valid from 16th November 2020) - (INR 10,000 + GST (18%) per delegate)
  • For Bulk Booking of More Than 5 Delegates – Please let us know your interests.

Conference Sponsor & Exhibition Stall – Should you wish to Sponsor, or purchase a Exhibition Stall (Booth) or a paid Speaker Slot, you can simply email your interest and queries to kavitha@virtueinsight.co.in or Call - +91 44 24762472


List of Main Topics

  • Review
  • predictions & updates on the global pharmacovigilance market Key regulations and pharmacovigilance system Pharmacovigilance and its importance in the pharmaceutical industry expands Discussion of pharmacovigilance and its effect in healthcare and patient care Demand for pharmacovigilance and consumer research Addressing concerns with drug safety by recognizing the risks associated with pharmaceutical products and reducing the possibility of any potential harm to patients Present legislation and proposals for pharmaceutical drugs endorse and carry out post marketing drug tests Planning pharmacovigilance and risk management Concentrating on the pharmacovigilance regulatory system in the form of risk management planning A performance risk management strategy across the drug development lifecycle The complexities of communicating and controlling the established quality risks Addressing global perspective of pharmacovigilance and risk management strategies Discussing about improving health outcomes and patient safety Real world evidence: The evolving regulatory landscape
  • information and integrated usage How real-world data is used today to produce evidence in major markets A new approach and support towards pharmacovigilance regulations New regulatory guidelines and laws governing pharmacovigilance Be part of a major networking opportunity

Speakers

BABITA KIRODIAN


Submission Instructions

  • Review, predictions & updates on the global pharmacovigilance market
  • Key regulations and pharmacovigilance system
  • Pharmacovigilance and its importance in the pharmaceutical industry expands
  • Discussion of pharmacovigilance and its effect in healthcare and patient care
  • Demand for pharmacovigilance and consumer research
  • Addressing concerns with drug safety by recognizing the risks associated with pharmaceutical products and reducing the possibility of any potential harm to patients
  • Present legislation and proposals for pharmaceutical drugs endorse and carry out post marketing drug tests
  • Planning pharmacovigilance and risk management
  • Concentrating on the pharmacovigilance regulatory system in the form of risk management planning
  • A performance risk management strategy across the drug development lifecycle
  • The complexities of communicating and controlling the established quality risks
  • Addressing global perspective of pharmacovigilance and risk management strategies
  • Discussing about improving health outcomes and patient safety
  • Real world evidence: The evolving regulatory landscape, information and integrated usage
  • How real-world data is used today to produce evidence in major markets
  • A new approach and support towards pharmacovigilance regulations
  • New regulatory guidelines and laws governing pharmacovigilance
  • Be part of a major networking opportunity


Submission Dates

Abstract Date
11-03-20

Registration Fee and Instructions

  • Early Bird Discounted Price (Vaild till 15th November 2020) - (INR 7,000 + GST (18%) per delegate)
  • Standard Price  (Valid from 16th November 2020) - (INR 10,000 + GST (18%) per delegate)
  • For Bulk Booking of More Than 5 Delegates – Please let us know your interests.